Urinary carnitine excretion in patients with heart failure. 1994

S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
Department of Cardiology, Kanazawa Medical University, Ishikawa, Japan.

To evaluate the fatty acid metabolism in heart failure, the semiquantitative analysis of urinary free carnitine and acylcarnitine was made by fast atom bombardment mass spectrometry (FABMS) in 22 patients (mean age 67.3 years) with heart failure and 19 age-matched healthy controls (average age 60.4 years). Urinary excretion of free carnitine was 0.20 +/- 0.118 ratio/mg creatinine in the healthy controls and 1.32 +/- 1.170 ratio/mg creatinine in the patients with heart failure. The latter value was significantly higher (p < 0.01). Patients with heart failure were classified into two groups according to the urinary free carnitine concentration. One was the high excretion group (2.19 +/- 0.102 ratio/mg creatinine, 12 cases) and the other was the low excretion group (0.37 +/- 0.212 ratio/mg creatinine, 10 cases). In the high excretion group, urinary acetylcarnitine was also increased, but no significant abnormalities were observed in the urinary organic acid profile. In the high group, 1 patient was classified as NYHA class III and 11 as NYHA class IV. Four patients died in the hospital. In the low excretion group, five patients were classified as NYHA class III and five as NYHA class IV. Only one patient died in the hospital. In the high group, patients with severe and prolonged heart failure tended to maintain higher values of urinary free carnitine. We could not find any abnormalities in fatty acid metabolism in patients with heart failure, but it is suspected that the patients who excrete large amounts of free carnitine into the urine, namely the patients with severe heart failure, have some possibility of carnitine deficiency.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002303 Cardiac Output, Low A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities. Low Cardiac Output,Low Cardiac Output Syndrome,Output, Low Cardiac
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D005260 Female Females
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000108 Acetylcarnitine An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS. Acetyl Carnitine,Medosan,Acetyl-L-Carnitine,Acetylcarnitine, (R)-Isomer,Alcar,Branigen,Levocarnitine Acetyl,Acetyl L Carnitine,Carnitine, Acetyl
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
February 2000, American journal of physiology. Heart and circulatory physiology,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
September 1998, European journal of clinical pharmacology,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
September 1991, The American journal of cardiology,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
January 2001, Likars'ka sprava,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
November 2000, Biochimica et biophysica acta,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
May 1976, The Journal of laboratory and clinical medicine,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
January 1981, JPEN. Journal of parenteral and enteral nutrition,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
January 2014, PloS one,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
July 2009, Circulation,
S Matsui, and T Sugita, and M Matoba, and E Murakami, and N Takekoshi, and T Shinka, and I Matsumoto
January 1985, JPEN. Journal of parenteral and enteral nutrition,
Copied contents to your clipboard!